Cheyne Capital Management (UK) LLP - RAPT THERAPEUTICS INC ownership

RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 100 filers reported holding RAPT THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.4%.

Quarter-by-quarter ownership
Cheyne Capital Management (UK) LLP ownership history of RAPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$332,400
-11.1%
20,0000.0%0.96%
-30.5%
Q2 2023$374,000
-73.7%
20,000
-72.2%
1.38%
-44.5%
Q4 2022$1,422,19471,8282.48%
Other shareholders
RAPT THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Ponoi Management, LLC 1,599,417$58,747,00054.16%
KPCB XV Associates, LLC 1,297,063$47,641,00037.58%
Ponoi II Management, LLC 145,401$5,341,0009.70%
Euclidean Capital LLC 432,900$15,900,0009.04%
Column Group LLC 1,402,008$51,496,0007.00%
AJU IB Investment Co., Ltd. 99,503$3,655,0005.09%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,148,321$42,178,0004.85%
Ghost Tree Capital, LLC 350,000$12,856,0004.61%
Velan Capital Investment Management LP 110,000$4,040,0003.14%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 443,619$16,294,0002.28%
View complete list of RAPT THERAPEUTICS INC shareholders